Cerus Endovascular and Balt this week announced a strategic distribution agreement to provide AB Medica with the exclusive rights to market and sell the Countour Neurovascular System and the Neqstent Coil Assisted Flow Diverter devices. The distribution agreement is currently limited to Germany. The financial details of the deal were not disclosed. “Our partnership with […]
Medtronic launches InterStim neurostim leads in U.S.
Medtronic (NYSE:MDT) today said it has launched its InterStim Micro neurostimulator in the U.S. The sacral neuromodulation therapy was FDA approved earlier this week and received CE mark approval in January. InterStim Micro is a neurostimulator that sends electrical impulses to the sacral nerves in the lower back to improve bladder and bowel control. The therapy […]
Abbott launches study of next-gen ablation catheter
Abbott (NYSE:ABT) today announced it has enrolled the first participants in its TactiFlex PAF IDE study to evaluate the performance of the TactiFlex sensor-enabled ablation catheter. The catheter is designed to treat people suffering from paroxysmal atrial fibrillation (PAF) with symptoms that are unable to be managed by medication. TactiFlex combines Abbott’s contact force-sensing technology within […]
Stryker brain aneurysm stent wins expanded indication for posterior use
Stryker (NYSE:SYK) recently announced its Neuroform Atlas Stent System received expanded indication from the FDA. The Neuroform Atlas Stent System is now approved for use in the posterior circulation. With the approval, the company said long term treatment is more feasible with the device. Prior to the new indication, the stent system was approved for use […]
Intersect ENT up on mixed bag Q2 results
Intersect ENT (NSDQ:XENT) posted second-quarter results today that beat the revenue consensus on Wall Street but missed on earnings. The Menlo Park, Calif.-based company report losses of -$223.1 million, or -71¢ per share, on sales of $9.8 million for the three months ended June 30, for a bottom-line sales loss of -63.3% compared with Q2 2019. […]
Zimmer Biomet beats The Street in Q2 results
Zimmer Biomet (NYSE:ZBH) posted second-quarter results today that beat the consensus on Wall Street. The Warsaw, Ind.-based company report losses of -$208.2 million, or -$1.00 per share, on sales of $1.2 billion for the three months ended June 30, for a bottom-line sales loss of -37% compared with Q2 2019. Adjusted to exclude one-time items, earnings […]
Avanos Medical up on Street-beating Q2 results
Avanos Medical (NYSE:AVNS) posted second-quarter results today that beat the consensus on Wall Street. The Alpharetta, Ga.-based company reported profits of $86.5 million, or -6¢ per share, on sales of $163.7 million for the three months ended June 30, for a bottom-line loss of -12.4% sales loss of -4.9% compared with Q2 2019. Adjusted to exclude […]
MiMedx appoints chief commercial officer
MiMedx recently announced it has appointed Rohit Kashyap as executive VP and chief commercial officer. Kashyap has more than 20 years of medical device experience. He most recently served as president of global commercial at Acelity. He has held a number of leaderships at Acelity since 1998. “MiMedx is a pioneer in the development of […]
Cantel Medical names new president
Cantel Medical (NYSE:CMD) today said it has appointed Peter Clifford as president and chief operating officer. Clifford previously served as executive VP of the company and will continue to report to CEO George Fotiades under his new role. “Over the past sixteen months, Peter has distinguished himself as executive VP and COO. He has demonstrated exceptional […]
The most innovative pharmaceutical agents of 2020
The Galien Foundation recently announced nominees for most innovative pharmaceutical agents for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical, pharmaceutical drugs and medical technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, […]
FDA announces new Class II medical device 510(k) exemptions
By Timothy Herr, Emergo Group The US Food and Drug Administration (FDA) published a final order listing categories of Class II medical devices that are now exempt from 510(k) premarket notification. The order also establishes new product codes and changes the title associated with one existing product code. Get the full story here at the […]
- 1
- 2
- 3
- …
- 107
- Next Page »
